Related Experiment Video
Updated: Apr 12, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of
Anggakusuma1, Inés Romero-Brey2, Carola Berger2
1Institute of Experimental Virology, Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany.
Insights
Hepatitis C virus infection increases cholesterol 25-hydroxylase (CH25H) in the liver. Its product, 25-hydroxycholesterol (25HC), inhibits viral RNA replication by disrupting the HCV replication factory.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) is a major global health concern, infecting 180 million people.
- Cholesterol 25-hydroxylase (CH25H) is an interferon-stimulated gene with known antiviral activity.
- The regulation and precise anti-HCV mechanisms of human CH25H (hCH25H) in the liver are not fully understood.
Purpose of the Study:
- To investigate the expression and regulation of hCH25H in the context of HCV infection.
- To characterize the antiviral effects of hCH25H and its product, 25-hydroxycholesterol (25HC), against HCV.
- To elucidate the molecular mechanisms by which 25HC inhibits HCV infectivity.
Main Methods:
- Analysis of hCH25H mRNA levels in HCV-positive human liver biopsies and primary hepatocytes.
- Induction of hCH25H expression by type I interferon in primary human hepatocytes.
- Assessment of HCV inhibition by hCH25H and 25HC in hepatoma cells and using subgenomic replicons.
- Electron microscopy to examine the effect of 25HC on viral replication structures.
Main Results:
- hCH25H mRNA levels were significantly elevated in HCV-infected liver tissues and cells.
- Type I interferon was identified as a primary inducer of transient hCH25H expression.
- hCH25H and 25HC demonstrated genotype-independent restriction of HCV infection.
- 25HC primarily inhibited HCV RNA replication by disrupting the membranous web, the viral replication factory.
Conclusions:
- HCV infection induces interferon-stimulated CH25H expression in vivo.
- The enzymatic product, 25HC, acts as a potent antiviral restricting HCV RNA replication.
- 25HC inhibits the formation of the viral replication factory, providing a novel therapeutic target.
Unlabelled:
Hepatitis C virus (HCV) is a positive-strand RNA virus that primarily infects human hepatocytes. Infections with HCV constitute a global health problem, with 180 million people currently chronically infected. Recent studies have reported that cholesterol 25-hydroxylase (CH25H) is expressed as an interferon-stimulated gene and mediates antiviral activities against different enveloped viruses through the production of 25-hydroxycholesterol (25HC). However, the intrinsic regulation of human CH25H (hCH25H) expression within the liver as well as its mechanistic effects on HCV infectivity remain elusive. In this study, we characterized the expression of hCH25H using liver biopsies and primary human hepatocytes. In addition, the antiviral properties of this protein and its enzymatic product, 25HC, were further characterized against HCV in tissue culture. Levels of hCH25H messenger RNA were significantly up-regulated both in HCV-positive liver biopsies and in HCV-infected primary human hepatocytes. The expression of hCH25H in primary human hepatocytes was primarily and transiently induced by type I interferon. Transient expression of hCH25H in human hepatoma cells restricted HCV infection in a genotype-independent manner. This inhibition required the enzymatic activity of CH25H. We observed an inhibition of viral membrane fusion during the entry process by 25HC, which was not due to a virucidal effect. Yet the primary effect by 25HC on HCV was at the level of RNA replication, which was observed using subgenomic replicons of two different genotypes. Further analysis using electron microscopy revealed that 25HC inhibited formation of the membranous web, the HCV replication factory, independent of RNA replication.
Conclusion:
Infection with HCV causes up-regulation of interferon-inducible CH25H in vivo, and its product, 25HC, restricts HCV primarily at the level of RNA replication by preventing formation of the viral replication factory.
More Related Videos
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

